InfuCare Rx receives investment from One Equity Partners
By HME News Staff
Updated 9:30 AM CST, Thu January 13, 2022
NEW YORK – InfuCare Rx, a national provider of specialty infusion therapies and comprehensive clinical therapy management services to patients with complex conditions, has received a strategic investment from One Equity Partners, a middle market private equity firm. "OEP's investment in InfuCare Rx aligns squarely with our thesis that care will continue to shift towards the lower-cost home setting and our focus on the importance of home-based management of complex chronic conditions," said Greg Belinfanti, senior managing director at OEP. "COVID has only accelerated the preference for home-and community-based care delivery; InfuCare Rx is well-positioned to meet this growing demand." Terms of the deal were not disclosed. The Fairfield, N.J.-based InfuCare Rx has locations in New Jersey, Pennsylvania, Maryland, Louisiana, California and Texas, and services more than 4,000 patients across 43 states using its InfuCare Rx digital care management platform.
Comments